Local Injection Methylene Blue Combined With Radiation in HNSCC Patients

NCT07435415 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Local Recurrent Tumor

Interventions

DRUG: Methylene Blue (50 mg/10ml)

Sponsor

China Medical University Hospital

Collaborators

[object Object]